What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?

Benzinga_recent_news12-10

Enveric Biosciences Inc. (NASDAQ:ENVB) shares jumped 73.82% in after-hours trading on Tuesday, climbing to $10.29. Check out the current price of ENVB stock here. According to Benzinga Pro data, the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590837211?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/09/Drug-Delivery-Ideas-Emerge.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-12-10 11:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590837211","market":"hk","top_or_hot":-1,"title":"What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?","media":"Benzinga_recent_news","content":"<div>\n<p>Enveric Biosciences Inc. (NASDAQ:ENVB) shares jumped 73.82% in after-hours trading on Tuesday, climbing to $10.29.\nCheck out the current price of ENVB stock here. \nAccording to Benzinga Pro data, the ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/12/49296195/what-sparked-enveric-biosciences-envb-74-surge-in-after-hours-trading\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-10 11:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/25/12/49296195/what-sparked-enveric-biosciences-envb-74-surge-in-after-hours-trading><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Enveric Biosciences Inc. (NASDAQ:ENVB) shares jumped 73.82% in after-hours trading on Tuesday, climbing to $10.29.\nCheck out the current price of ENVB stock here. \nAccording to Benzinga Pro data, the ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/12/49296195/what-sparked-enveric-biosciences-envb-74-surge-in-after-hours-trading\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ENVB","symbol_name":"Enveric Biosciences","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/25/12/49296195/what-sparked-enveric-biosciences-envb-74-surge-in-after-hours-trading","article_id":"2590837211","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/09/Drug-Delivery-Ideas-Emerge.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/12/49296195/what-sparked-enveric-biosciences-envb-74-surge-in-after-hours-trading","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2590837211","pubTimestamp":1765337460,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Enveric Biosciences shares soared 73.82% in after-hours trading after the company received a patent allowance for its EVM301 Series molecules.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ENVB":"Enveric Biosciences","BK4007":"制药"},"translate_title":"是什么引发Enveric Biosciences(ENVB)盘后交易飙升74%？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ENVB":1.5},"content_text":"Enveric Biosciences Inc. (NASDAQ:ENVB) shares jumped 73.82% in after-hours trading on Tuesday, climbing to $10.29.\nCheck out the current price of ENVB stock here. \nAccording to Benzinga Pro data, the stock closed on Tuesday at $5.92, down 2.47%.\nThe Massachusetts-based biotech company received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application related to its EVM301 Series molecules, which are being developed as potential treatments for mental health disorders.\nThe patent, titled \"N-heterocycle substituted tryptamine derivatives and methods of using,\" includes composition and method-of-use claims that could expand Enveric's pipeline by covering additional neuroplastogenic, non-hallucinogenic molecules for treating neuropsychiatric and addiction disorders.\nSee Also: What’s Going On With The Uptick In Tesla Stock Today?\nAccording to the company, the patent will strengthen Enveric's EVM301 Series portfolio, which includes its lead asset, EB-003, a non-hallucinogenic serotonin receptor agonist in development for depressive and anxiety disorders.\nJoseph Tucker, Director and CEO of Enveric, said, \"We continue to work diligently to reinforce our patent estate around our lead asset, EB-003, and the EVM301 Series of compounds, which we see as vital to generating value for Enveric shareholders.\"\nThe stock has seen a 91.57% decline so far this year.\nWith a market capitalization of $3.45 million, ENVB's annual range has been $4.88 to $96.30.\nBenzinga Edge Stock Rankings indicate that ENVB stock has a negative price trend across all time frames. Track the performance of other players in this segment.\nRead Next:\nImage via Shutterstock/ Gorodenkoff\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590837211","isCrawlerRequest":true}